Premium
Drugmaker Gland Pharma Ltd, the first Indian company controlled by a Chinese firm to float an initial public offering, is seeking a valuation of as much as Rs 24,492 crore ($3.3 billion at current exchange rates) through the share sale. Hyderabad-based Gland Pharma, which is majority-owned by China’s Shanghai Fosun Pharmaceutical ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
